Eric Zhang
Vorstandsvorsitzender bei AKSO Biopharmaceutical, Inc.
Vermögen: 174 010 $ am 31.12.2023
Aktive Positionen von Eric Zhang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AKSO Biopharmaceutical, Inc. | Vorstandsvorsitzender | - | - |
| Gründer | - | - |
Karriereverlauf von Eric Zhang
Ehemalige bekannte Positionen von Eric Zhang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ARAVIVE, INC. | Direktor/Vorstandsmitglied | 12.10.2018 | 02.10.2023 |
| Independent Dir/Board Member | 12.10.2018 | 02.10.2023 | |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | 01.06.2016 | 01.10.2018 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Direktor/Vorstandsmitglied | 12.10.2018 | - |
Ausbildung von Eric Zhang
| Queen's University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 2 |
Operativ
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARAVIVE, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
| AKSO Biopharmaceutical, Inc. |
- Börse
- Insiders
- Eric Zhang
- Erfahrung
